mechanism of action of efanesoctocog alfa to treat hemophilia a
Published 1 year ago • 947 plays • Length 3:38Download video MP4
Download video MP3
Similar videos
-
3:26
efanesoctocog alfa shows promise as treatment for previously treated severe hemophilia a
-
54:36
efanesoctocog: a truly long-acting fviii replacement product
-
3:03
insights into the mechanism of action of fitusiran & the value of this agent in hemophilia treatment
-
9:36
hemophilia (year of the zebra)
-
38:17
defining the role of ehl replacement clotting factors in the modern management of hemophilia a
-
57:12
developments in the management of hemophilia
-
57:07
11/16/18: the end of hemophilia?
-
8:08
an overview of pharmacologic treatment for hemophilia
-
7:35
an overview of the hemophilia treatment paradigm
-
5:20
clot control: a story about hemophilia | cincinnati children's
-
1:34
understanding hemophilia
-
2:10
treating hemophilia a
-
0:36
hemophilia treatment in the 1990's: recombinant to the rescue!
-
55:11
factor product utilization and health outcomes in patients with hemophilia a and b
-
38:23
tx innovation in hemophilia a: integrating ehl replacement clotting factors into clinical practice
-
18:51
isth academy presentation: half-life extended factor viii for the treatment of hemophilia a
-
6:32
targeted factor viii delivery in hemophilia with inhibitors
-
12:14
factor viii and hemophilia a
-
20:08
hemophilia a - bleeding - most comprehensive explanation - hematology, bleeding, and coagulation